Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study
Open Access
- 27 August 2012
- journal article
- Published by Springer Science and Business Media LLC in BMC Musculoskeletal Disorders
- Vol. 13 (1), 158
- https://doi.org/10.1186/1471-2474-13-158
Abstract
Background Patients with rheumatoid arthritis (RA) are known to be at increased risk of infection, particularly if they are taking drugs with immunomodulatory effects. There is a need for more information on the risk of influenza in patients with RA. Methods A retrospective cohort study was carried out using data gathered from a large US commercial health insurance database (Thomson Reuters Medstat MarketScan) from 1 January 2000 to 31 December 2007. Patients were ≥18 years of age, with at least two RA claims diagnoses. The database was scanned for incidence of seasonal influenza and its complications on or up to 30 days after an influenza diagnosis in RA patients and matched controls. Other factors accounted for included medical conditions, use of disease-modifying anti-rheumatic drugs (DMARDs), use of biological agents, influenza vaccination and high- or low-dose corticosteroids. Incidence rate ratios (IRRs) were calculated for influenza and its complications in patients with RA. Results 46,030 patients with RA and a matching number of controls had a median age of 57 years. The incidence of influenza was higher in RA patients than in controls (409.33 vs 306.12 cases per 100,000 patient-years), and there was a 2.75-fold increase in incidence of complications in RA. Presence or absence of DMARDs or biologics had no significant effect. The adjusted IRR of influenza was statistically significant in patients aged 60–69 years, and especially among men. A significantly increased rate of influenza complications was observed in women and in both genders combined (but not in men only) when all age groups were combined. In general, the risk of influenza complications was similar in RA patients not receiving DMARDs or biologics to that in all RA patients. Pneumonia rates were significantly higher in women with RA. Rates of stroke/myocardial infarction (MI) were higher in men, although statistical significance was borderline. Conclusions RA is associated with increased incidence of seasonal influenza and its complications. Gender- and age-specific subgroup data indicate that women generally have a greater rate of complications than men, but that men primarily have an increased rate of stroke and MI complications. Concomitant DMARD or biological use appears not to significantly affect the rate of influenza or its complications.This publication has 20 references indexed in Scilit:
- The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotypeAnnals Of The Rheumatic Diseases, 2010
- How to reduce morbidity and mortality from chest infections in rheumatoid arthritisClinical Medicine, 2010
- Infections induced by low-dose corticosteroids in rheumatoid arthritis: A systematic literature reviewJoint Bone Spine, 2010
- Identification of new risk factors for pneumonia: population-based case-control studyBritish Journal of General Practice, 2009
- Use of glucocorticoids and risk of infectionsAutoimmunity Reviews, 2008
- Vaccines: Vaccination in Patients with Chronic Rheumatic or Autoimmune DiseasesClinical Infectious Diseases, 2008
- Life‐threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanerceptArthritis & Rheumatism, 2002
- Frequency of infection in patients with rheumatoid arthritis compared with controls: A population‐based studyArthritis & Rheumatism, 2002
- Infectious arthritis complicating rheumatoid arthritis and other chronic rheumatic disordersArthritis & Rheumatism, 1989
- Infection in Rheumatoid ArthritisArthritis & Rheumatism, 1971